*N*-Allenamides are readily available allenic scaffolds and valuable building blocks in organic synthesis, and therefore have received considerable attention in the past decades.^[@cit1],[@cit2]^ Significant effort has been devoted to the cycloaddition reactions of *N*-allenamides,^[@cit3]^ and several enantioselective \[*n* + 2\] reactions have been explored as reliable approaches to synthesise a diverse array of carbo- or heterocyclic substructures ([Scheme 1](#sch1){ref-type="fig"}).^[@cit4]--[@cit6]^ Mascareñas *et al.* developed an elegant enantioselective intermolecular \[4 + 2\] cycloaddition reaction between *N*-allenamides and dienes using a gold/chiral carbene catalyst ([Scheme 1a](#sch1){ref-type="fig"}).^[@cit4]^ González\'s and Zhang\'s groups disclosed \[2 + 2\] cycloadditions of *N*-allenamides with olefins, leading to optically active cyclobutanes with excellent enantioselectivities ([Scheme 1b](#sch1){ref-type="fig"}).^[@cit5a],[@cit5c]^ Interestingly, in the latter case a dearomative \[4 + 2\] reaction of 3-styrylindoles was observed by varying indolic *N*-substituents.^[@cit5c]^ A dearomative \[2 + 2\] cycloaddition reaction of *N*-allenamides with indoles was realized by Bandini\'s group as a powerful route to access cyclobutane-fused indolines with excellent enantioselectivities.^[@cit5b]^ The \[3 + 2\] reaction was also developed by Chen and co-workers in an enantioselective cycloaddition of *N*-allenamides with nitrones ([Scheme 1c](#sch1){ref-type="fig"}).^[@cit6a]^ It should be noted that all of the above reactions mainly relied on *N*-allenamide activation to form an α,β-unsaturated imine intermediate and hence regioselectively occurred at its distal CC bond. In sharp contrast, the reactivity of *N*-allenamide at the proximal CC bond has remained rarely studied.^[@cit7]^ The only enantioselective example was reported by Zhang\'s group in an asymmetric \[3 + 2\] reaction involving *in situ* annulation of yne-enones ([Scheme 1d](#sch1){ref-type="fig"}).^[@cit6b]^ Meanwhile, all of the precedent examples exclusively relied on chiral noble gold catalysts. Moreover, despite these advances, no example of cycloaddition of *N*-allenamides with imines has appeared for the synthesis of nitrogen-bearing four-membered heterocycles even in their racemic version.^[@cit1a]^ Therefore, the development of new cycloaddition reactions of *N*-allenamides and a new catalyst system to synthesize important heterocyclic cores is highly attractive.

![Reactivity of *N*-allenamides in enantioselective cycloaddition reactions.](c6sc05450a-s1){#sch1}

Azetidine derivatives are important entities in organic chemistry and are frequently occurring scaffolds in natural products and bioactive molecules. Enantioselective \[2 + 2\] reaction of imines provides a straightforward route to such strained four-membered heterocycles, including β-lactams.^[@cit8],[@cit9]^ However, as a unique building block, *N*-allenamide has not been utilized in the \[2 + 2\] cycloaddition with imines. We envisioned that an enantioselective \[2 + 2\] cycloaddition of *N*-allenamides with imines might occur *via* an imine activation strategy using a chiral Lewis acid catalyst, where *N*-allenamide acts as a nucleophile (like enamide) to attack the imine at its more electron-rich proximal CC bond and hence delivers highly substituted azetidines through the cyclization that follows.^[@cit10]^ Herein, we report the first enantioselective \[2 + 2\] cycloaddition reaction of *N*-allenamides with cyclic *N*-sulfonyl α-ketiminoesters^[@cit11]^ to afford fused polysubstituted chiral azetidines bearing quaternary stereocenters with excellent enantioselectivities ([Scheme 1e](#sch1){ref-type="fig"}). A non-noble chiral nickel catalyst was applied for the first time in the cycloaddition reactions of *N*-allenamides.

Our study began with the model reaction between *N*-allenamide **1a** and cyclic α-ketiminoester **2a**. Pleasingly, an initial test revealed that the complex of Ni(ClO~4~)~2~·6H~2~O/chiral bisoxazoline **L1** smoothly promoted the reaction in DCE and in the presence of 4 Å molecular sieves at room temperature, resulting in the desired product **3aa** in 83% yield, albeit with a poor ee value ([Table 1](#tab1){ref-type="table"}, entry 1). Subsequent ligand examination implied that chiral substituents of oxazoline were critical to enantioselectivity (entries 2--7). Ligands **L2--L3** bearing isopropyl or *tert*-butyl substituents led to poor enantioselectivities (entries 2 and 3), while **L4**, containing phenyl substituents, was the best choice to give **3aa** in 99% ee and 82% yield (entry 4).^[@cit12]^ Inferior results were obtained when **L5** and **L6** bearing *trans*- or *cis*-diphenyl substituents were used (entries 5 and 6). Phosphine ligand **L7** led to **3aa** with a moderate yield and ee value (entry 7). Solvent investigation showed that excellent enantioselectivities with relatively lower yields were observed in CH~2~Cl~2~, THF, and toluene (entries 8--10). Either poor yield or poor enantioselectivity was obtained in Et~2~O or MeCN (entries 11 and 12). Changing the Lewis acid to Cu(OTf)~2~ or Mg(OTf)~2~ resulted in an almost racemic product (entries 13 and 14), while Zn(OTf)~2~ led to a relatively lower ee (entry 15). Other perchlorate metallic salts, such as Mg(ClO~4~)~2~, Zn(ClO~4~)~2~·6H~2~O, and Cu(ClO~4~)~2~·6H~2~O, were also tested and inferior results were obtained (entries 16--18). Finally, a poor yield was obtained in the absence of 4 Å MS due to the decomposition of *N*-allenamide **1a** (entry 19). It is noteworthy that only one isomer was detected in these reactions.

###### Optimization of the reaction conditions[^*a*^](#tab1fna){ref-type="fn"}

  ![](c6sc05450a-u1.jpg){#ugr1}                                                                   
  ------------------------------------------ -------- ---------------------- ------------ ------- -----
  1                                          **L1**   Ni(ClO~4~)~2~·6H~2~O   DCE          83      18
  2                                          **L2**   Ni(ClO~4~)~2~·6H~2~O   DCE          75      15
  3                                          **L3**   Ni(ClO~4~)~2~·6H~2~O   DCE          69      11
  4                                          **L4**   Ni(ClO~4~)~2~·6H~2~O   DCE          82      99
  5                                          **L5**   Ni(ClO~4~)~2~·6H~2~O   DCE          62      92
  6                                          **L6**   Ni(ClO~4~)~2~·6H~2~O   DCE          65      93
  7                                          **L7**   Ni(ClO~4~)~2~·6H~2~O   DCE          70      60
  8                                          **L4**   Ni(ClO~4~)~2~·6H~2~O   CH~2~Cl~2~   57      96
  9                                          **L4**   Ni(ClO~4~)~2~·6H~2~O   THF          51      99
  10                                         **L4**   Ni(ClO~4~)~2~·6H~2~O   Toluene      60      95
  11                                         **L4**   Ni(ClO~4~)~2~·6H~2~O   Et~2~O       23      91
  12                                         **L4**   Ni(ClO~4~)~2~·6H~2~O   CH~3~CN      90      10
  13                                         **L4**   Cu(OTf)~2~             DCE          65      7
  14                                         **L4**   Mg(OTf)~2~             DCE          75      \<5
  15                                         **L4**   Zn(OTf)~2~             DCE          70      85
  16                                         **L4**   Mg(ClO~4~)~2~          DCE          70      28
  17                                         **L4**   Zn(ClO~4~)~2~·6H~2~O   DCE          55      46
  18                                         **L4**   Cu(ClO~4~)~2~·6H~2~O   DCE          Trace   ---
  19[^*d*^](#tab1fnd){ref-type="table-fn"}   **L4**   Ni(ClO~4~)~2~·6H~2~O   DCE          45      99

^*a*^Reaction conditions: **1a** (0.3 mmol), **2a** (0.2 mmol), LA (10 mol%), ligand (12 mol%), and 4 Å molecular sieves (100 mg) in solvent (1.0 M) at room temperature; **L7**: (*S*)-BINAP.

^*b*^Isolated yield.

^*c*^Determined by chiral HPLC.

^*d*^Without 4 Å MS.

With the optimal reaction conditions found, we then investigated the scope of *N*-allenamides **1** and *N*-sulfonyl α-ketiminoesters **2**. As shown in [Table 2](#tab2){ref-type="table"}, α-ketiminoesters **2a--2d**, bearing different ester groups, were first evaluated. Good yields and enantioselectivities were afforded in these reactions in spite of a slightly decreased ee value for the iso-propyl substrate **2b** (entries 1--4). Substituents attached at the C5--C7 position of the α-ketiminoesters were then investigated (entries 5--14). The substituted groups, such as halide, --CF~3~, --OCF~3~, --OMe, and alkyl groups, were well tolerated to afford the corresponding products with excellent enantioselectivities and modest to good yields. The reaction yields of the α-ketiminoesters containing electron-donating substituents were slightly higher than those of the α-ketiminoesters bearing electron-deficient substituents (entries 5--7 *vs.* 8--11).

###### Substrate scope of the \[2 + 2\] reaction[^*a*^](#tab2fna){ref-type="fn"}

  ![](c6sc05450a-u2.jpg){#ugr2}                                                                     
  ------------------------------- ------------------------ ------------------------- -------------- ----
  1                               **1a** (4-Me/H)          **2a** (H/Et)             82 (**3aa**)   99
  2                               **1a** (4-Me/H)          **2b** (H/^i^Pr)          75 (**3ab**)   90
  3                               **1a** (4-Me/H)          **2c** (H/Me)             76 (**3ac**)   99
  4                               **1a** (4-Me/H)          **2d** (H/^*n*^Bu)        80 (**3ad**)   98
  5                               **1a** (4-Me/H)          **2e** (5-OMe/Et)         77 (**3ae**)   99
  6                               **1a** (4-Me/H)          **2f** (5-Me/Et)          73 (**3af**)   97
  7                               **1a** (4-Me/H)          **2g** (5-^*t*^Bu/Et)     70 (**3ag**)   98
  8                               **1a** (4-Me/H)          **2h** (5-Cl/Et)          64 (**3ah**)   99
  9                               **1a** (4-Me/H)          **2i** (5-F/Et)           70 (**3ai**)   95
  10                              **1a** (4-Me/H)          **2j** (5-CF~3~/Et)       52 (**3aj**)   99
  11                              **1a** (4-Me/H)          **2k** (5-OCF~3~/Et)      55 (**3ak**)   98
  12                              **1a** (4-Me/H)          **2l** (7-Cl/Et)          64 (**3al**)   94
  13                              **1a** (4-Me/H)          **2m** (7-OCF~3~/Et)      76 (**3am**)   93
  14                              **1a** (4-Me/H)          **2n** (6,7-(CH)~4~/Et)   70 (**3an**)   94
  15                              **1b** (4-Me/4-Me)       **2a** (H/Et)             75 (**3ba**)   99
  16                              **1c** (4-Me/4-Br)       **2a** (H/Et)             67 (**3ca**)   97
  17                              **1d** (4-Me/3-OMe)      **2a** (H/Et)             78 (**3da**)   99
  18                              **1f** (H/H)             **2a** (H/Et)             70 (**3fa**)   99
  19                              **1g** (4-^*t*^Bu/H)     **2a** (H/Et)             80 (**3ga**)   99
  20                              **1h** (4-OMe/H)         **2a** (H/Et)             70 (**3ha**)   94
  21                              **1i** (4-CF~3~/H)       **2a** (H/Et)             66 (**3ia**)   99
  22                              **1j** (3,4-(CH)~4~/H)   **2a** (H/Et)             80 (**3ja**)   94
  23                              **1k** (4-Cl/H)          **2a** (H/Et)             72 (**3ka**)   98
  24                              **1k** (4-Cl/H)          **2e** (5-OMe/Et)         75 (**3ke**)   99
  25                              **1k** (4-Cl/H)          **2h** (5-Cl/Et)          90 (**3kh**)   98
  26                              **1b** (4-Me/4-Me)       **2e** (5-OMe/Et)         85 (**3be**)   98

^*a*^Reaction conditions are identical to those in entry 4 in [Table 1](#tab1){ref-type="table"}.

^*b*^Isolated yield of the only isomer.

^*c*^Determined by chiral HPLC.

The scope of *N*-allenamide **4** was also evaluated. By varying the aryl substituents and the sulfonyl groups, a number of substituted *N*-allenamides were tested and afforded the expected products in good yields and with excellent ee values (entries 15--26). It is worth noting that the reaction of *N*-benzyl substrate **1e** also produced the desired azetidine **3ea** in 71% yield and 99% ee (eqn (1)). Moreover, a racemic 3-substituted *N*-allenamide **1l** was also used in this reaction to give the desired product **3la** in 75% yield and 95% ee (eqn (2)). Interestingly, a kinetic resolution process of *N*-allenamide **1l** was observed and the remaining starting material was isolated in 70% yield and 68% ee, which represents a promising route to chiral *N*-allenamide.^[@cit13]^ In addition, *N*-allenyl pyrrolidinone **4a** and oxazolidinone **4b** were also tested as substrates in this transformation, however, acrylaldehyde **5a** was isolated as the major product instead of the desired cycloaddition adduct ([Scheme 2](#sch2){ref-type="fig"}). Although a poor yield of **5a** was obtained for the reaction of **4a**, the yield and ee were both remarkably improved by employing *N*-oxazolidinone **4b** as the substrate. Several other α-ketiminoesters were then examined in the reactions with **4b** to afford the corresponding acrylaldehydes **5b--5e** in acceptable yields and with good to excellent enantioselectivities.

![Reaction of *N*-allenyl pyrrolidinone **4a** and oxazolidinone **4b** with α-ketiminoesters.](c6sc05450a-s2){#sch2}

Cyclic six-membered *N*-sulfonyl α-ketimines were also examined as substrates in this reaction. The desired \[2 + 2\] adducts **7a** and **7b** were afforded with good yields and enantioselectivities ([Scheme 3](#sch3){ref-type="fig"}). In the case of a naphthyl-ketimine substrate, the pure adduct could not be obtained; however, acrylaldehyde **8c** was isolated in 63% yield and with 82% ee by treating the mixture with 10 mol% TsOH after the reaction.

![Reaction of *N*-allenamide **1a** with cyclic six-membered *N*-sulfonylketimines **6**.](c6sc05450a-s3){#sch3}

A gram-scale reaction of **1a** with **2a** was carried out to afford product **3aa** in 75% yield and 99% ee, showing good reliability of the present process ([Scheme 4](#sch4){ref-type="fig"}). Synthetic transformations of **3aa** were then performed. A Pd/C-catalyzed hydrogenation of **3aa** afforded saturated azetidine **9** as a single isomer in 76% yield and 97% ee. Reduction of **3aa** in the presence of LiAlH~4~ led to homoallylic alcohol **10** in 90% yield and 99% ee. TsOH-catalyzed hydrolysis of **3aa** afforded acrylaldehyde **5a** in 80% yield without any loss of enantioselectivity.

![Gram-scale reaction and synthetic transformations of product **3aa**. ^*a*^ Conditions are identical to those in entry 4 in [Table 1](#tab1){ref-type="table"}; ^*b*^ Pd/C (10 mol%), H~2~ (1 atm) in MeOH (0.1 M) at 25 °C for 1 h; ^*c*^ TsOH·H~2~O (10 mol%) in DCE (0.2 M) at 60 °C for 3 h; ^*d*^ LiAlH~4~ (2.0 equiv.) in THF (0.1 M) at 25 °C for 1 h.](c6sc05450a-s4){#sch4}

A tentative stepwise mechanism that accounts for the \[2 + 2\] reaction is proposed in [Scheme 5](#sch5){ref-type="fig"}. α-Ketiminoester **2** is firstly activated by the chiral nickel catalyst in a 1,4-binding coordination fashion to form intermediate **A**. Subsequent enantioselective nucleophilic addition of *N*-allenamide **1** or **4** to **A** generates intermediate **B**. The \[2 + 2\] product **3** was then regioselectively formed by the intramolecular cyclization of the amide with iminium (path a) and the catalyst was released simultaneously. The formation of acrylaldehyde **5** instead of the \[2 + 2\] adduct is probably owing to the hydrolysis of intermediate **B** when employing *N*-allenyl oxazolidinone **4b** as the substrate (path b).

![Proposed reaction pathway.](c6sc05450a-s5){#sch5}

Conclusions
===========

In summary, we have developed a novel catalytic enantioselective \[2 + 2\] cycloaddition reaction of *N*-allenamides with cyclic *N*-sulfonyl α-ketiminoesters, which delivered a range of polysubstituted chiral azetidines bearing quaternary stereocenters as valuable bioactive compounds in good yields and with excellent enantioselectivities. The complex of Ni(ClO~4~)~2~ with commercially available chiral bisoxazoline ligands was utilized for the first time as a chiral catalyst in the cycloaddition reaction of *N*-allenamides. Broad substrate scope was observed for allenamides and cyclic *N*-sulfonylketimines. It is noteworthy that acrylaldehyde products were obtained when employing *N*-allenyl oxazolidinones as substrates.
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